Why the study?
Does intravenous verapamil alter electrophysiologic parameters in children undergoing cardiac catheterization?
Does intravenous verapamil alter electrophysiologic parameters in children undergoing cardiac catheterization?
Intravenous verapamil prolongs the effective and functional refractory periods of the cardiac conduction system, particularly the AV node, in children, providing a mechanistic basis for its use in reentrant supraventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Verapamil may affect conduction intervals in children during catheterization; leaves open its role in pediatric SVT pending controlled studies.
The electrophysiologic effects of verapamil, a slow channel blocker, were investigated during diagnostic cardiac catheterization in 24 children premedicated with lytic cocktail. The ages ranged from 50 days to 12 years. Twenty had congenital and 4 had rheumatic heart disease. Surface EKG, high intra-atrial and His bundle electrograms were obtained in all before and 5 min after a single dose of verapamil (0.15 mg/Kg, max 5 mg iv). In 14 cases complete electropysiologic studies were performed using the atrial pacing and extrastimulus technique. Due to variability of the resting heart rates and the effect of cycle length on refractory periods each paced with identical S1-S1 interval before and after verapamil, thus allowing each case to serve as his own control. Verapamil prolonged the corrected AH interval in all (mean +/- SD; from 116 +/- 37 to 152 +/- 41 msec, p less than 0.01) and shortened the HV interval in 15/24 (mean +/- SD: from 55 +/- 13 to 47 +/- 9.9 msec, p less than 0.05). The effective and functional refractory periods of the total conduction system, the AV node (ERPAVN) and atrium (ERPA) increased significantly in 10/14. The most profound effect was on ERPAVN and ERPA (25.54 +/- 29 and 19.27 +/- 21.81 percent mean percent increase +/- SD respectively, p less than 0.01 and p less than 0.02). Our findings show that verapamil prolongs the effective and functional refractory periods of the cardiac conduction system with maximal effects on the AV node, thus suggesting the mechanism of its effectiveness in the treatment of reentrant supraventricular arrhythmias.
No takes yet. Share an insight, caveat, or question.
Shakibi et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: